Pathogenesis and management of Kawasaki disease (Q22305933)

Europe PubMed Central

title

Pathogenesis and management of Kawasaki disease (English)

0 references

1 reference

1 reference

Anne H Rowley

1

Anne H

Rowley

1 reference

PubMed publication ID

20109049

8 February 2023

Stanford T Shulman

series ordinal

2

author given names

Stanford T

author last names

Shulman

1 reference

PubMed publication ID

20109049

Expert Review of Anti-infective Therapy

8 February 2023

language of work or name

English

0 references

publication date

February 2010

0 references

published in

0 references

volume

8

0 references

issue

2

0 references

page(s)

197-203

0 references

cites work

A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Infliximab treatment for refractory Kawasaki syndrome

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Refractory Kawasaki disease

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Early treatment with intravenous immunoglobulin in patients with Kawasaki disease

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Molecular genetics of Kawasaki disease

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Kawasaki syndrome hospitalizations in the United States, 1997 and 2000.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Oligoclonal IgA response in the vascular wall in acute Kawasaki disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

IgA plasma cells in vascular tissue of patients with Kawasaki syndrome.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Cardiac transplantation for Kawasaki disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Gamma globulin re-treatment in Kawasaki disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Protection of guinea pigs against experimental Argentine hemorrhagic fever by purified human IgG: importance of elimination of infected cells

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2845298

Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight.

27 September 2017

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.109

Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.109

Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.109

Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.109

Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.109

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.09.109

Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?

21 January 2018

1 reference

12 December 2020

Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease

1 reference

12 December 2020

Coronary artery bypass grafting for Kawasaki disease

1 reference

12 December 2020

Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset

1 reference

12 December 2020

Systemic Arterial Expression of Matrix Metalloproteinases 2 and 9 in Acute Kawasaki Disease

1 reference

12 December 2020

Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease

1 reference

12 December 2020

High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease

1 reference

12 December 2020

Interventional treatment for children with severe coronary artery stenosis with calcification after long-term Kawasaki disease

1 reference

12 December 2020

Cell adhesion molecule expression in coronary artery aneurysms in acute Kawasaki disease

1 reference

12 December 2020

Cloning the arterial IgA antibody response during acute Kawasaki disease

1 reference

12 December 2020

Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium

1 reference

12 December 2020

A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12

1 reference

12 December 2020

Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease

1 reference

12 December 2020

Initial intravenous gammaglobulin treatment failure in Kawasaki disease

1 reference

12 December 2020

IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease

1 reference

12 December 2020

How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease?

1 reference

12 December 2020

Identifiers

DOI

10.1586/ERI.09.109

1 reference

1 reference

1 reference

PubMed publication ID

20109049

1 reference